These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17195721)

  • 21. Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study.
    Konstenius M; Jayaram-Lindström N; Beck O; Franck J
    Drug Alcohol Depend; 2010 Apr; 108(1-2):130-3. PubMed ID: 20015599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cotempla XR-ODT--another long-acting methylphenidate for ADHD.
    Med Lett Drugs Ther; 2017 Nov; 59(1533):183-185. PubMed ID: 29125594
    [No Abstract]   [Full Text] [Related]  

  • 23. Increase in Menstrual Cycle Length Induced by Extended-Release Methylphenidate in an Adolescent with Attention-Deficit/Hyperactivity Disorder.
    Mutlu C; Bahalı K; Gunes H; Adaletli H
    J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):860-861. PubMed ID: 26397126
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-acting methylphenidate has an effect on aggressive behavior in children with attention-deficit/hyperactivity disorder.
    Sinzig J; Döpfner M; Lehmkuhl G; ; Uebel H; Schmeck K; Poustka F; Gerber WD; Günter M; Knölker U; Gehrke M; Hässler F; Resch F; Brünger M; Ose C; Fischer R
    J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):421-32. PubMed ID: 17822338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylphenidate in attention deficit hyperactivity disorder and bipolar disorder.
    Kummer A; Teixeira A
    Australas Psychiatry; 2008 Dec; 16(6):458-9. PubMed ID: 19034996
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical and cognitive response to extended-release methylphenidate (Medikinet) in attention deficit/hyperactivity disorder: efficacy evaluation.
    Fernández-Jaén A; Fernández-Mayoralas DM; Pardos A; Calleja-Pérez B; Muñoz Jareño N
    Adv Ther; 2009 Dec; 26(12):1097-110. PubMed ID: 20082241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New long-acting stimulants in children with ADHD.
    Rains A; Scahill L
    J Child Adolesc Psychiatr Nurs; 2004; 17(4):177-9. PubMed ID: 15742799
    [No Abstract]   [Full Text] [Related]  

  • 28. Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder.
    Ross RG
    Am J Psychiatry; 2006 Jul; 163(7):1149-52. PubMed ID: 16816217
    [No Abstract]   [Full Text] [Related]  

  • 29. Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy.
    Tan M; Appleton R
    Arch Dis Child; 2005 Jan; 90(1):57-9. PubMed ID: 15613514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An update on the safety of psychostimulants for the treatment of attention-deficit/hyperactivity disorder.
    Groenman AP; Schweren LJ; Dietrich A; Hoekstra PJ
    Expert Opin Drug Saf; 2017 Apr; 16(4):455-464. PubMed ID: 28277842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylphenidate and comorbid anxiety disorder in children with both chronic multiple tic disorder and ADHD.
    Gadow KD; Nolan EE
    J Atten Disord; 2011 Apr; 15(3):246-56. PubMed ID: 20378921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
    Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological management of treatment-induced insomnia in ADHD.
    Kratochvil CJ; Lake M; Pliszka SR; Walkup JT
    J Am Acad Child Adolesc Psychiatry; 2005 May; 44(5):499-501. PubMed ID: 15843773
    [No Abstract]   [Full Text] [Related]  

  • 34. Once-daily OROS methylphenidate is safe and well tolerated in adolescents with attention-deficit/hyperactivity disorder.
    McGough JJ; McBurnett K; Bukstein O; Wilens TE; Greenhill L; Lerner M; Stein M
    J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):351-6. PubMed ID: 16768642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-acting methylphenidate reduces collision rates of young adult drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Davis M; Mikami AY; Singh H; Merkel RL; Burket R
    J Clin Psychopharmacol; 2012 Apr; 32(2):225-30. PubMed ID: 22367664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case report of Concerta misuse in a patient with comorbid substance use disorder and attention deficit hyperactivity disorder.
    Rizkallah E; Legault L; Pampoulova T; Lévesque S; Bélanger M; Stavro K; Chiasson JP; Potvin S
    Am J Addict; 2011; 20(5):478-9. PubMed ID: 21838849
    [No Abstract]   [Full Text] [Related]  

  • 37. Successful desensitization of methylphenidate-induced rash.
    Confino-Cohen R; Goldberg A
    J Child Adolesc Psychopharmacol; 2005 Aug; 15(4):703-5. PubMed ID: 16190802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term relationship between methylphenidate and tobacco consumption and nicotine craving in adults with ADHD in a prospective cohort study.
    Bron TI; Bijlenga D; Kasander MV; Spuijbroek AT; Beekman AT; Kooij JJ
    Eur Neuropsychopharmacol; 2013 Jun; 23(6):542-54. PubMed ID: 22809706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
    Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
    J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Question 2 Should a child with ADHD and epilepsy be given ritalin?
    Boyes C
    Arch Dis Child; 2010 Sep; 95(9):759-61. PubMed ID: 20716679
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.